Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 6: How could she adopt? WRAL Investigates adoption law after a mother is accused of murdering two adopted children.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Myt Netherlands Parent B.V. ADR
(NY:
MYTE
)
6.260
+0.120 (+1.95%)
Official Closing Price
Updated: 4:10 PM EST, Nov 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Myt Netherlands Parent B.V. ADR
< Previous
1
2
3
4
Next >
Analyst Ratings for MYT Netherlands Parent
October 25, 2022
Over the past 3 months, 5 analysts have published their opinion on MYT Netherlands Parent (NYSE:MYTE) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Mytheresa Announces First Quarter Fiscal Year 2023 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences
October 18, 2022
From
MYT Netherlands Parent B.V.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
September 29, 2022
Gainers Shift Technologies (NASDAQ:SFT) shares increased by 5.0% to $0.69 during Thursday's after-market session. The market value of their outstanding shares is at $58.8 million.
Via
Benzinga
4 Analysts Have This to Say About MYT Netherlands Parent
September 20, 2022
MYT Netherlands Parent (NYSE:MYTE) has observed the following analyst ratings within the last quarter:
Via
Benzinga
What 4 Analyst Ratings Have To Say About MYT Netherlands Parent
September 20, 2022
MYT Netherlands Parent (NYSE:MYTE) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Where MYT Netherlands Parent Stands With Analysts
September 20, 2022
Analysts have provided the following ratings for MYT Netherlands Parent (NYSE:MYTE) within the last quarter:
Via
Benzinga
Mytheresa Clocks 7.7% Sales Growth In Q4
September 15, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 23, 2022
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Keybanc Slashes PT On This Stock By 50%, Plus This Analyst Predicts $100 For PayPal
September 20, 2022
Susquehanna lowered the price target for PayPal Holdings, Inc. (NASDAQ: PYPL) from $115 to $100. PayPal shares fell 2.4% to $92.73 in pre-market trading.
Via
Benzinga
Q4 and Full FY22 Results: Mytheresa Accelerates Growth in Q4 and Concludes the Full Fiscal Year With a GMV Growth of 21.3%, a Two-Year GMV Growth of 66.3% and a Record Profitability of 9.6% Adjusted EBITDA Margin
September 15, 2022
From
Mytheresa
Via
Business Wire
Earnings Scheduled For September 15, 2022
September 15, 2022
Companies Reporting Before The Bell • Boqii Holding (NYSE:BQ) is estimated to report earnings for its first quarter.
Via
Benzinga
Preview: MYT Netherlands Parent's Earnings
September 14, 2022
MYT Netherlands Parent (NYSE:MYTE) is set to give its latest quarterly earnings report on Thursday, 2022-09-15. Here's what investors need to know before the announcement. Analysts estimate that MYT...
Via
Benzinga
Earnings Scheduled For February 16, 2022
February 16, 2022
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million.
Via
Benzinga
Mytheresa Announces Fourth Quarter and Full Fiscal Year 2022 Earnings Release and Conference Call
August 18, 2022
From
MYT Netherlands Parent B.V.
Via
Business Wire
What 5 Analyst Ratings Have To Say About MYT Netherlands Parent
May 16, 2022
Over the past 3 months, 5 analysts have published their opinion on MYT Netherlands Parent (NYSE:MYTE) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Q3 FY22 Results: Mytheresa reports GMV growth of 13.2% in Q3 FY22, a 67% two-year growth, stable profitability and targets strong full fiscal year 2022
May 10, 2022
From
MYT Netherlands Parent B.V.
Via
Business Wire
Mytheresa to Participate in Upcoming Investor Conferences
May 09, 2022
From
MYT Netherlands Parent B.V.
Via
Business Wire
Mytheresa Announces Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
April 19, 2022
From
MYT Netherlands Parent B.V.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022
April 12, 2022
Upgrades
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
March 29, 2022
Gainers Trxade Health (NASDAQ:MEDS) shares increased by 18.0% to $2.76 during Tuesday's regular session. Trxade Health's stock is trading at a volume of 16.1...
Via
Benzinga
UBS Upgrades This Luxury E-Commerce Company - Read Why
March 24, 2022
UBS analyst Kunal Madhukar upgraded MYT Netherlands Parent BV (NYSE: MYTE) (Mytheresa) to Buy from Neutral. Madhukar said he is optimistic about the company...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022
March 24, 2022
Upgrades For iRobot Corp (NASDAQ:IRBT), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, iRobot showed an EPS of $1....
Via
Benzinga
Mytheresa to Participate in Upcoming Investor Conferences
March 21, 2022
From
MYT Netherlands Parent B.V.
Via
Business Wire
Expert Ratings For MYT Netherlands Parent
March 18, 2022
Within the last quarter, MYT Netherlands Parent (NYSE:MYTE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...
Via
Benzinga
56 Biggest Movers From Yesterday
February 17, 2022
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead...
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 16, 2022
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral...
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower Ahead Of Fed Minutes
February 16, 2022
US stocks opened on a downbeat note this morning following the release of several economic reports.
Via
Benzinga
Q2 FY22 Results: Mytheresa Reports Strong GMV Growth of 26.2% in Q2 FY22 and Increases Guidance for Full Fiscal Year 2022
February 16, 2022
From
MYT Netherlands Parent B.V.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
February 15, 2022
Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...
Via
Benzinga
Mytheresa Announces Second Quarter Fiscal Year 2022 Earnings Release and Conference Call
January 20, 2022
From
MYT Netherlands Parent B.V.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.